CVS Health (CVS) Tops Q2 EPS by 22c, Sales Beat; Raises Outlook
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $101.30 +3.03%
Revenue Growth %: +1.2%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +1.2%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.40, $0.22 better than the analyst estimate of $2.18. Revenue for the quarter came in at $80.6 billion versus the consensus estimate of $76.4 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.40-$8.60, versus prior of $8.20-$8.40 and the consensus of $8.36.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- CVS Pharmacy® expands GLP‑1 support to lower costs, improve access, and help patients stay on therapy
- MP Materials seen largely insulated after China export-control move
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
